KGTFY yields 5.63% · PFE yields 6.13%● Live data
📍 KGTFY pulled ahead of the other in Year 1
Combined, KGTFY + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of KGTFY + PFE for your $10,000?
Krung Thai Bank Public Company Limited provides various commercial banking products and services. The company operates through three segments: Retail Banking, Wholesale Banking, and Treasury and Investment. It provides various retail banking products and services, including current, savings, and fixed deposit accounts; time and foreign currency deposits; personal and housing loans; debit, travel, cash and top up, and credit cards; investment services; travel, motor, and home asset insurance products; money transfer, payment and top up, foreign exchange, and overseas education services; and e-banking services. The company also offers SME loans for small and medium businesses; and international business loans. In addition, it provides corporate banking products and services comprising cash management services, such as collection, liquidity management, and transfer and payment services; fixed deposit and current accounts; foreign currency and term deposits; cards; Fx, interest rate, equity, commodity, and credit derivatives; financial advisory services related to merger and acquisition transactions; financial advisory, underwriting, and selling agent services for products offered through the equity capital markets; project finance advisory and feasibility study services, as well as e-banking services; and investment solutions, such as government and corporate bonds, structured notes, and investment units. The company provides its services through a network of branches in Thailand and various centers internationally. Krung Thai Bank Public Company Limited was founded in 1966 and is headquartered in Bangkok, Thailand.
Full KGTFY Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.